Experimental evidence suggests that in individuals with chronic kidney disease (CKD), elevated FGF-23 levels diminish calcitriol synthesis and contribute to the activation of the RAAS, potentially leading to increased renin production (23). This evidence concerns the gene FGF23 and chronic kidney disease.